Journalist Hunt

Resources ▾

Journalist DatabaseFor JournalistsPricing
LoginSign up

Sushmita Panda - Journalist Profile | Connect with top journalists

View 's journalist industries, journalist types, location, and media outlets. Use Journalist Hunt to get connected with top journalists in seconds.

Get connected with journalists today
Pharma Reporter, Citeline

Sushmita Panda

Verified

Pharma Reporter, Citeline

New Delhi, Delhi

Beats

Primary beats

BusinessWorldUnited StatesReligionFinancePoliticsCrimeEducationJusticeMetro New York

Secondary beats

Public FinanceNailsPharmaceuticalsFashionlifestyleHealth CoachingItalian FoodMedicalTVAlcoholMetaverseVeganGlobal MarketFilmInvoice Finance

Biography

Sushmita Panda is a New Delhi-based journalist with over six years of experience covering the healthcare and pharmaceutical sectors. She has reported on critical issues including drug patents and discovery, rare diseases, innovative therapies, women’s health, Neglected Tropical Diseases (NTDs), mental health, drug access, and regulatory affairs. Over the years, she has authored numerous in-depth stories and on-ground reports on diseases prevalent in India, including several exclusives and interviews with industry leaders. An alumna of the Asian College of Journalism and the University of Delhi, Sushmita has worked with national and international publications such as Financial Express, Sputnik, The Sunday Guardian, and India TV.

Final Covers

BusinessHealth and Social issues. Politics

Doesn’t Cover

Entertainment, Lifestyle, and sports.

Journalist Type

Reporter

Seniority Positions

-

Industries

Information Services

Medium Formats

Print,Digital

Content

Total articles 1198

  • Available on paid plans

    US is harming its own citizens by putting excessive tariffs: MTaI

    By Sushmita Panda Verified

    Apr. 03, 2025

  • Available on paid plans

    Pharma tariff exemption: Temporary relief, but higher tariffs may be imposed later, warns analyst

    By Sushmita Panda Verified

    Apr. 03, 2025

  • Available on paid plans

    Novartis gets USFDA nod for its therapy to treat Berger's disease - Healthcare News

    By Sushmita Panda Verified

    Apr. 03, 2025

As seen in

Space Daily,India TV,Sputnik,Sunday Guardian Live,Yerepouni Daily News,MSN Canada,MSN India,Ein News,Citeline,The Daily Guardian,Financial Express

Company Info

Citeline

New York, New York, United States

+1 646-957-8919

Founded:



Journalist Hunt

Email us

contact@journalisthunt.com
Terms and ConditionsRefund PolicyPrivacy Policy

Copywright © 2025, Journalist Hunt. All right reserved